Johnson & Johnson (JNJ)

144.24
1.18 0.82
NYSE : Health Technology
Prev Close 143.06
Open 143.27
Day Low/High 143.19 / 144.98
52 Wk Low/High 120.11 / 148.99
Volume 7.50M
Avg Volume 6.61M
Exchange NYSE
Shares Outstanding 2.66B
Market Cap 377.26B
EPS 5.70
P/E Ratio 26.31
Div & Yield 3.80 (2.57%)

Latest News

Weekly Roundup

Stocks log gains for week on Fed rate-cut hopes and possible easing of U.S. trade tensions with China.

10 Stocks and 10 ETFs for Socially Conscious Investors

10 Stocks and 10 ETFs for Socially Conscious Investors

Investors have shown an increasing interest in ESG Investing. These top investment vehicles emphasize strong business operations and social responsibilities.

HP, Mercadolibre, Bausch Health: 'Mad Money' Lightning Round

HP, Mercadolibre, Bausch Health: 'Mad Money' Lightning Round

Jim Cramer takes a look at HP, Mercadolibre, Bausch Health, ArcelorMittal, Johnson & Johnson, Transdigm Group, PPL Corp. McKesson and more.

Weekly Roundup

A quiet week offered a chance to get ready for volatility around the FOMC meeting and G-20 summit later this month.

Good Value or Value Trap?: Cramer's 'Mad Money' Recap (Wednesday 6/12/19)

Good Value or Value Trap?: Cramer's 'Mad Money' Recap (Wednesday 6/12/19)

Jim Cramer says spotting the bottom is really tough; and if you're too early, you'll get hit hard.

Jim Cramer: A Tale of Two Stocks

Jim Cramer: A Tale of Two Stocks

I want you to remember Eli Lilly and Johnson & Johnson the next time you are about to dump a stock because of some bits of bad news.

Weekly Roundup

Markets surge in face of multiple uncertainties.

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Thursday 6/6/19)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Thursday 6/6/19)

Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.

Trimming a Healthcare Name for a Large Gain

We think Abbott Labs is a terrific company, but the stock already has a big premium and that may limit the potential of future gains.

Johnson & Johnson Releases 2018 Health For Humanity Report

Johnson & Johnson Releases 2018 Health For Humanity Report

Sharing Progress in Environmental, Social and Governance Practices

MyPhillyLawyer Helps Secure $80 Million Victory For Transvaginal Mesh Patient

MyPhillyLawyer Helps Secure $80 Million Victory For Transvaginal Mesh Patient

PHILADELPHIA, June 3, 2019 /PRNewswire/ -- A Philadelphia jury awarded more than $80 million to a 75-year-old woman in a transvaginal mesh lawsuit against Ethicon, a subsidiary of Johnson & Johnson (NYSE: JNJ).

Last Week's Portfolio Changes

We initiated a new position in Mastercard and made several ratings and price target changes.

Johnson & Johnson: Follow Warren Buffett's Advice and Be Greedy

Johnson & Johnson: Follow Warren Buffett's Advice and Be Greedy

Overblown litigation concerns have scared off many investors, making now a good time to buy.

Weekly Roundup

Rough week for stocks capped by new front in tariff wars with Mexico.

Buying Back Shares in a Semi Equipment Maker Stock We Recently Sold Higher

We are adding to our Lam Research position.

Johnson & Johnson Ordered to Pay $300 Million Punitive Award in Talc Case

Johnson & Johnson Ordered to Pay $300 Million Punitive Award in Talc Case

Johnson & Johnson is ordered to pay a $300 million punitive award to a woman who said she contracted cancer through the use of the company's talc-based products.

Video: Jim's Daily Rundown for Thursday

Jim gives his view on an analyst take that Cisco is a "relative safe haven in this macro backdrop," he provides thoughts on Palo Alto Networks, he discusses Viacom, and much more!

Jim Cramer: This Is Now an Emotional Market

Jim Cramer: This Is Now an Emotional Market

When traders are flailing and investors are drowning, examples work best to illustrate what happens before a bottom is reached.

It's Getting Emotional: Cramer's 'Mad Money' Recap (Wednesday 5/29/19)

It's Getting Emotional: Cramer's 'Mad Money' Recap (Wednesday 5/29/19)

The current selloff is finally starting to prompt overwrought responses from investors, Jim Cramer says.

Buffett's Berkshire Hathaway Closes Below $300,000

Buffett's Berkshire Hathaway Closes Below $300,000

Shares of Warren Buffett's investment vehicle, Berkshire Hathaway, ended the day below $300,000 for the first time since late March.

Stocks Slide as Bond Yields Tumble, China Threatens Rare Earths Ban

Stocks Slide as Bond Yields Tumble, China Threatens Rare Earths Ban

Stocks tumble Wednesday as falling bond yields and a rare earth ban threat by China rattle Wall Street.

Markets Slumping Wednesday but Our Cash Allows Us to Be Opportunistic

Our 'stay the course' plan during these moments is to use scale and look to buy high-quality merchandise (stocks) that we previously sold higher and are now trading at a discount.

Jim Cramer: How to Rebalance Your Portfolio in a Volatile Market

Jim Cramer: How to Rebalance Your Portfolio in a Volatile Market

Jim Cramer weighs in on how investors can rebalance their portfolios in a volatile market.

Band-Aids Cannot Help Johnson & Johnson in This Decline

Band-Aids Cannot Help Johnson & Johnson in This Decline

Let's take a serious look at the charts and indicators.

Video: Jim's Daily Rundown for Wednesday

Jim discusses yesterday's buys/sells (including Kohl's and Five Below) and this morning's purchase of Johnson & Johnson, and much more!

Adding to Johnson & Johnson

We believe today's selloff provides us the opportunity to begin to buy back shares we sold higher.

Teva Plummets on Downgrade Following $85M Opioid Settlement

Teva Plummets on Downgrade Following $85M Opioid Settlement

Shares of Teva plummet Tuesday after UBS downgrades the stock to neutral from buy in light of opioid-related litigation.

TheStreet Quant Rating: B (Buy)